Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Non-tumoral uptake of 68Ga-FAPI-04 PET: A retrospective study

View through CrossRef
ObjectiveFibroblast activation protein (FAP)-targeting radiopharmaceutical based on the FAP-specific inhibitor (FAPI) is considered as a potential alternative agent to FDG for tumor-specific imaging. However, FAP is also expressed in normal adult tissues. The aim of this study was to explore the image features of non-tumoral regions with high uptake of 68Ga-FAPI-04 in positron emission tomography (PET) imaging and to reveal the physiological mechanisms of these regions.MaterialA total of 137 patients who underwent whole-body 68Ga-FAPI-04 PET/MR (n=46) or PET/CT (n=91) were included in this retrospective study. Three experienced nuclear medicine physicians determined the non-tumoral regions according to other imaging modalities (CT, MRI, 18F-FDG PET, or ultrasound), clinical information, or pathological results. The regions of interest (ROIs) were drawn manually, and the maximum standardized uptake value (SUVmax) was measured.ResultsA total of 392 non-tumoral uptake regions were included in this study. The included physiological regions were uterus (n=38), submandibular gland (n=118), nipple (n=37), gingiva (n=65), and esophagus (n=31). The incidence of 68Ga-FAPI-04 uptake in physiological regions was independent of age, the tracer uptakes in the gingiva and esophagus were more common in male patients (p=0.006, 0.009), while that in the nipple was more common in female patients (p < 0.001). The included benign regions were inflammatory lymph node (n =10), pneumonia (n=13), atherosclerosis (n=10), pancreatitis (n=18), osteosclerosis (n=45), and surgical scar (n=7). No significant difference was observed in SUVmax between physiological and benign regions.ConclusionsA number of organs exhibit physiological uptakes of 68Ga-FAPI-04. Our study showed that regions with high 68Ga-FAPI-04 uptake did not necessarily represent malignancy. Being familiar with physiological and typical benign 68Ga-FAPI-04 uptake regions can be helpful for physicians to interpret images and to make an accurate diagnosis.
Title: Non-tumoral uptake of 68Ga-FAPI-04 PET: A retrospective study
Description:
ObjectiveFibroblast activation protein (FAP)-targeting radiopharmaceutical based on the FAP-specific inhibitor (FAPI) is considered as a potential alternative agent to FDG for tumor-specific imaging.
However, FAP is also expressed in normal adult tissues.
The aim of this study was to explore the image features of non-tumoral regions with high uptake of 68Ga-FAPI-04 in positron emission tomography (PET) imaging and to reveal the physiological mechanisms of these regions.
MaterialA total of 137 patients who underwent whole-body 68Ga-FAPI-04 PET/MR (n=46) or PET/CT (n=91) were included in this retrospective study.
Three experienced nuclear medicine physicians determined the non-tumoral regions according to other imaging modalities (CT, MRI, 18F-FDG PET, or ultrasound), clinical information, or pathological results.
The regions of interest (ROIs) were drawn manually, and the maximum standardized uptake value (SUVmax) was measured.
ResultsA total of 392 non-tumoral uptake regions were included in this study.
The included physiological regions were uterus (n=38), submandibular gland (n=118), nipple (n=37), gingiva (n=65), and esophagus (n=31).
The incidence of 68Ga-FAPI-04 uptake in physiological regions was independent of age, the tracer uptakes in the gingiva and esophagus were more common in male patients (p=0.
006, 0.
009), while that in the nipple was more common in female patients (p < 0.
001).
The included benign regions were inflammatory lymph node (n =10), pneumonia (n=13), atherosclerosis (n=10), pancreatitis (n=18), osteosclerosis (n=45), and surgical scar (n=7).
No significant difference was observed in SUVmax between physiological and benign regions.
ConclusionsA number of organs exhibit physiological uptakes of 68Ga-FAPI-04.
Our study showed that regions with high 68Ga-FAPI-04 uptake did not necessarily represent malignancy.
Being familiar with physiological and typical benign 68Ga-FAPI-04 uptake regions can be helpful for physicians to interpret images and to make an accurate diagnosis.

Related Results

First Clinical Experience of 68Ga-FAPI PET/CT in Tertiary Cancer Center: Identifying Pearls and Pitfalls
First Clinical Experience of 68Ga-FAPI PET/CT in Tertiary Cancer Center: Identifying Pearls and Pitfalls
Background/Objectives: Over the past four years, 68Ga-fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography (PET/CT) has been established ...
Value of [68Ga]Ga-FAPI-04 Imaging in the Diagnosis of Renal Fibrosis
Value of [68Ga]Ga-FAPI-04 Imaging in the Diagnosis of Renal Fibrosis
Abstract PurposeRenal fibrosis is a pathological state in the progression of chronic kidney disease. Early detection and treatment are vital to prolong the survival of pati...
SEMANA DE ENFERMAGEM E SEUS ASPECTOS SOCIAIS NA VALORIZAÇÃO PROFISSIONAL: UM RELATO DE EXPERIÊNCIA DO GRUPO PET-ENFERMAGEM
SEMANA DE ENFERMAGEM E SEUS ASPECTOS SOCIAIS NA VALORIZAÇÃO PROFISSIONAL: UM RELATO DE EXPERIÊNCIA DO GRUPO PET-ENFERMAGEM
A enfermagem é o pilar da assistência pois está na linha de frente do cuidado holístico, todavia esta é estigmatizada e desvalorizada, assim como não possui reconhecimento consider...
68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617
68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617
Abstract Background Differentiated thyroid carcinoma (DTC) is the most common type of thyroid cancer. Treatment with surgery, radioactive iodine (RAI), and TSH suppression is effec...
Diagnostic performance of Ga-68 FAPI 04 PET/CT in colorectal malignancies
Diagnostic performance of Ga-68 FAPI 04 PET/CT in colorectal malignancies
Aim To evaluate the role of Ga-68 fibroblast activation protein inhibitor 04 PET/computed tomography (FAPI) in colorectal cancers (CRCs) in terms of diagnostic accuracy...
Scale down and optimized automated production of [68Ga]68Ga-DOTA-ECL1i PET tracer targeting CCR2 expression
Scale down and optimized automated production of [68Ga]68Ga-DOTA-ECL1i PET tracer targeting CCR2 expression
Abstract Background: recently it has been identified a short peptide that showed allosteric antagonism against C-C motif chemokine receptor 2 (CCR2) expressed on inflammato...
FAPα+CAFs: Targeting the Tumor Microenvironment for Revolutionary Cancer Therapies
FAPα+CAFs: Targeting the Tumor Microenvironment for Revolutionary Cancer Therapies
Background: Within the tumor microenvironment (TME), (FAPα+CAFs) referred to as Cancer-Associated Fibroblasts (CAFs) that express Fibroblast Activation Protein α (FAPα) have gained...
68Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters
68Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters
Background Gliomas are the most common primary central nervous system tumors, of which the malignant gliomas account for 60%–75%. The primary and secondary brain malign...

Back to Top